Washington: A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial.The clinical trial was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH .
Narendra Modi sent emissaries to me: Geelani
Pak journalist Hamid Mir shot at in Karachi
Book from RAW, a new threat to UPA?
IPL Scam: BCCI`s emergency meet to decide Srinivasan`s fate tomorrow